{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Model Validation on Data from Drugs.com"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T00:31:55.695439Z",
     "start_time": "2019-07-08T00:31:54.630410Z"
    }
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import sklearn\n",
    "from sklearn.externals import joblib"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T00:31:55.749783Z",
     "start_time": "2019-07-08T00:31:55.698248Z"
    }
   },
   "outputs": [],
   "source": [
    "val_data = pd.read_csv(\"/Users/shristi/Documents/InsightDataProject/Data/Drugs.com/Valset.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:37:31.837115Z",
     "start_time": "2019-07-08T01:37:31.809388Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Names of drugs in pair</th>\n",
       "      <th>DDI type predicted using DeepDDI</th>\n",
       "      <th>DeepDDI output sentence for the corresponding DDI type</th>\n",
       "      <th>Consistent with information on the corresponding DDI in Drugs.com?</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>529</th>\n",
       "      <td>Telaprevir;Bepridil</td>\n",
       "      <td>10</td>\n",
       "      <td>The serum concentration of Bepridil can be inc...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>530</th>\n",
       "      <td>Telaprevir;Oxycodone</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Oxycodone can be decreased w...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>531</th>\n",
       "      <td>Telaprevir;Quinidine</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Quinidine can be decreased w...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532</th>\n",
       "      <td>Telaprevir;Temsirolimus</td>\n",
       "      <td>10</td>\n",
       "      <td>The serum concentration of Temsirolimus can be...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>533</th>\n",
       "      <td>Telaprevir;Toremifene</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Toremifene can be decreased ...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>534</th>\n",
       "      <td>Telithromycin;Oxycodone</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Oxycodone can be decreased w...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>535</th>\n",
       "      <td>Telithromycin;Temsirolimus</td>\n",
       "      <td>10</td>\n",
       "      <td>The serum concentration of Temsirolimus can be...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>536</th>\n",
       "      <td>Temozolomide;Clozapine</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Clozapine can be decreased w...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>537</th>\n",
       "      <td>Tenofovir disoproxil;Etodolac</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Etodolac can be decreased wh...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>538</th>\n",
       "      <td>Terbutaline;Labetalol</td>\n",
       "      <td>51</td>\n",
       "      <td>Terbutaline may increase the atrioventricular ...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>539</th>\n",
       "      <td>Thiotepa;Clozapine</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Clozapine can be decreased w...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>540</th>\n",
       "      <td>Thiotepa;Leflunomide</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Leflunomide can be decreased...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>541</th>\n",
       "      <td>Ticagrelor;Apixaban</td>\n",
       "      <td>46</td>\n",
       "      <td>Ticagrelor may increase the anticoagulant acti...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>542</th>\n",
       "      <td>Ticagrelor;Ibrutinib</td>\n",
       "      <td>10</td>\n",
       "      <td>The serum concentration of Ibrutinib can be in...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>543</th>\n",
       "      <td>Ticlopidine;Apixaban</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Apixaban can be decreased wh...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>544</th>\n",
       "      <td>Tizanidine;Aliskiren</td>\n",
       "      <td>35</td>\n",
       "      <td>Tizanidine may decrease the antihypertensive a...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>545</th>\n",
       "      <td>Tizanidine;Fenoldopam</td>\n",
       "      <td>67</td>\n",
       "      <td>Tizanidine may increase the hypotensive activi...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>546</th>\n",
       "      <td>Tizanidine;Hydroflumethiazide</td>\n",
       "      <td>67</td>\n",
       "      <td>Tizanidine may increase the hypotensive activi...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>547</th>\n",
       "      <td>Tizanidine;Hydroflumethiazide</td>\n",
       "      <td>47</td>\n",
       "      <td>Tizanidine may increase the antihypertensive a...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>548</th>\n",
       "      <td>Tizanidine;Phenoxybenzamine</td>\n",
       "      <td>67</td>\n",
       "      <td>Tizanidine may increase the hypotensive activi...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>549</th>\n",
       "      <td>Tizanidine;Phentolamine</td>\n",
       "      <td>67</td>\n",
       "      <td>Tizanidine may increase the hypotensive activi...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>550</th>\n",
       "      <td>Tizanidine;Reserpine</td>\n",
       "      <td>52</td>\n",
       "      <td>Tizanidine may increase the bradycardic activi...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>551</th>\n",
       "      <td>Tizanidine;Tolazoline</td>\n",
       "      <td>67</td>\n",
       "      <td>Tizanidine may increase the hypotensive activi...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>552</th>\n",
       "      <td>Topiramate;Cyclobenzaprine</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Cyclobenzaprine can be decre...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>553</th>\n",
       "      <td>Topiramate;Dicyclomine</td>\n",
       "      <td>9</td>\n",
       "      <td>The serum concentration of Dicyclomine can be ...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>554</th>\n",
       "      <td>Topiramate;Doxepin</td>\n",
       "      <td>54</td>\n",
       "      <td>Topiramate may increase the central nervous sy...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>555</th>\n",
       "      <td>Topiramate;Iloperidone</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Iloperidone can be decreased...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>556</th>\n",
       "      <td>Topiramate;Imipramine</td>\n",
       "      <td>54</td>\n",
       "      <td>Topiramate may increase the central nervous sy...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>557</th>\n",
       "      <td>Topiramate;Nortriptyline</td>\n",
       "      <td>54</td>\n",
       "      <td>Topiramate may increase the central nervous sy...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>558</th>\n",
       "      <td>Topiramate;Risperidone</td>\n",
       "      <td>67</td>\n",
       "      <td>Topiramate may increase the hypotensive activi...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>609</th>\n",
       "      <td>Venlafaxine;Lorcaserin</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Lorcaserin can be decreased ...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>610</th>\n",
       "      <td>Venlafaxine;Maprotiline</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Maprotiline can be decreased...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>611</th>\n",
       "      <td>Venlafaxine;Milnacipran</td>\n",
       "      <td>10</td>\n",
       "      <td>The serum concentration of Milnacipran can be ...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>612</th>\n",
       "      <td>Venlafaxine;Selegiline</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Selegiline can be decreased ...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>613</th>\n",
       "      <td>Venlafaxine;Sertraline</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Sertraline can be decreased ...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>614</th>\n",
       "      <td>Venlafaxine;Tapentadol</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Tapentadol can be decreased ...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>615</th>\n",
       "      <td>Venlafaxine;Tranylcypromine</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Tranylcypromine can be decre...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>616</th>\n",
       "      <td>Venlafaxine;Trimipramine</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Trimipramine can be decrease...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>617</th>\n",
       "      <td>Verapamil;Bisoprolol</td>\n",
       "      <td>52</td>\n",
       "      <td>Verapamil may increase the bradycardic activit...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>618</th>\n",
       "      <td>Verapamil;Carvedilol</td>\n",
       "      <td>10</td>\n",
       "      <td>The serum concentration of Carvedilol can be i...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>619</th>\n",
       "      <td>Verapamil;Flecainide</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Flecainide can be decreased ...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>620</th>\n",
       "      <td>Verapamil;Flibanserin</td>\n",
       "      <td>10</td>\n",
       "      <td>The serum concentration of Flibanserin can be ...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>621</th>\n",
       "      <td>Verapamil;Guanfacine</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Guanfacine can be decreased ...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>622</th>\n",
       "      <td>Verapamil;Oxycodone</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Oxycodone can be decreased w...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>623</th>\n",
       "      <td>Vilazodone;Nortriptyline</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Nortriptyline can be decreas...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>624</th>\n",
       "      <td>Vorapaxar;Apixaban</td>\n",
       "      <td>46</td>\n",
       "      <td>Vorapaxar may increase the anticoagulant activ...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>625</th>\n",
       "      <td>Vorapaxar;Argatroban</td>\n",
       "      <td>46</td>\n",
       "      <td>Vorapaxar may increase the anticoagulant activ...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>626</th>\n",
       "      <td>Vorapaxar;Bivalirudin</td>\n",
       "      <td>46</td>\n",
       "      <td>Vorapaxar may increase the anticoagulant activ...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>627</th>\n",
       "      <td>Vorapaxar;Edoxaban</td>\n",
       "      <td>46</td>\n",
       "      <td>Vorapaxar may increase the anticoagulant activ...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>628</th>\n",
       "      <td>Vorapaxar;Warfarin</td>\n",
       "      <td>10</td>\n",
       "      <td>The serum concentration of Warfarin can be inc...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>629</th>\n",
       "      <td>Voriconazole;Bepridil</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Bepridil can be decreased wh...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>630</th>\n",
       "      <td>Voriconazole;Oxycodone</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Oxycodone can be decreased w...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>631</th>\n",
       "      <td>Voriconazole;Toremifene</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Toremifene can be decreased ...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>632</th>\n",
       "      <td>Voriconazole;Vinblastine</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Vinblastine can be decreased...</td>\n",
       "      <td>Yes</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>633</th>\n",
       "      <td>Voriconazole;Vinorelbine</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Vinorelbine can be decreased...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>634</th>\n",
       "      <td>Vortioxetine;Tramadol</td>\n",
       "      <td>72</td>\n",
       "      <td>Vortioxetine may increase the neuroexcitatory ...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>635</th>\n",
       "      <td>Ziprasidone;Topiramate</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Topiramate can be decreased ...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>636</th>\n",
       "      <td>Ziprasidone;Trifluoperazine</td>\n",
       "      <td>6</td>\n",
       "      <td>The metabolism of Trifluoperazine can be decre...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>637</th>\n",
       "      <td>Zonisamide;Aripiprazole</td>\n",
       "      <td>9</td>\n",
       "      <td>The serum concentration of Aripiprazole can be...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>638</th>\n",
       "      <td>Zonisamide;Risperidone</td>\n",
       "      <td>67</td>\n",
       "      <td>Zonisamide may increase the hypotensive activi...</td>\n",
       "      <td>No</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>110 rows Ã— 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            Names of drugs in pair  DDI type predicted using DeepDDI  \\\n",
       "529            Telaprevir;Bepridil                                10   \n",
       "530           Telaprevir;Oxycodone                                 6   \n",
       "531           Telaprevir;Quinidine                                 6   \n",
       "532        Telaprevir;Temsirolimus                                10   \n",
       "533          Telaprevir;Toremifene                                 6   \n",
       "534        Telithromycin;Oxycodone                                 6   \n",
       "535     Telithromycin;Temsirolimus                                10   \n",
       "536         Temozolomide;Clozapine                                 6   \n",
       "537  Tenofovir disoproxil;Etodolac                                 6   \n",
       "538          Terbutaline;Labetalol                                51   \n",
       "539             Thiotepa;Clozapine                                 6   \n",
       "540           Thiotepa;Leflunomide                                 6   \n",
       "541            Ticagrelor;Apixaban                                46   \n",
       "542           Ticagrelor;Ibrutinib                                10   \n",
       "543           Ticlopidine;Apixaban                                 6   \n",
       "544           Tizanidine;Aliskiren                                35   \n",
       "545          Tizanidine;Fenoldopam                                67   \n",
       "546  Tizanidine;Hydroflumethiazide                                67   \n",
       "547  Tizanidine;Hydroflumethiazide                                47   \n",
       "548    Tizanidine;Phenoxybenzamine                                67   \n",
       "549        Tizanidine;Phentolamine                                67   \n",
       "550           Tizanidine;Reserpine                                52   \n",
       "551          Tizanidine;Tolazoline                                67   \n",
       "552     Topiramate;Cyclobenzaprine                                 6   \n",
       "553         Topiramate;Dicyclomine                                 9   \n",
       "554             Topiramate;Doxepin                                54   \n",
       "555         Topiramate;Iloperidone                                 6   \n",
       "556          Topiramate;Imipramine                                54   \n",
       "557       Topiramate;Nortriptyline                                54   \n",
       "558         Topiramate;Risperidone                                67   \n",
       "..                             ...                               ...   \n",
       "609         Venlafaxine;Lorcaserin                                 6   \n",
       "610        Venlafaxine;Maprotiline                                 6   \n",
       "611        Venlafaxine;Milnacipran                                10   \n",
       "612         Venlafaxine;Selegiline                                 6   \n",
       "613         Venlafaxine;Sertraline                                 6   \n",
       "614         Venlafaxine;Tapentadol                                 6   \n",
       "615    Venlafaxine;Tranylcypromine                                 6   \n",
       "616       Venlafaxine;Trimipramine                                 6   \n",
       "617           Verapamil;Bisoprolol                                52   \n",
       "618           Verapamil;Carvedilol                                10   \n",
       "619           Verapamil;Flecainide                                 6   \n",
       "620          Verapamil;Flibanserin                                10   \n",
       "621           Verapamil;Guanfacine                                 6   \n",
       "622            Verapamil;Oxycodone                                 6   \n",
       "623       Vilazodone;Nortriptyline                                 6   \n",
       "624             Vorapaxar;Apixaban                                46   \n",
       "625           Vorapaxar;Argatroban                                46   \n",
       "626          Vorapaxar;Bivalirudin                                46   \n",
       "627             Vorapaxar;Edoxaban                                46   \n",
       "628             Vorapaxar;Warfarin                                10   \n",
       "629          Voriconazole;Bepridil                                 6   \n",
       "630         Voriconazole;Oxycodone                                 6   \n",
       "631        Voriconazole;Toremifene                                 6   \n",
       "632       Voriconazole;Vinblastine                                 6   \n",
       "633       Voriconazole;Vinorelbine                                 6   \n",
       "634          Vortioxetine;Tramadol                                72   \n",
       "635         Ziprasidone;Topiramate                                 6   \n",
       "636    Ziprasidone;Trifluoperazine                                 6   \n",
       "637        Zonisamide;Aripiprazole                                 9   \n",
       "638         Zonisamide;Risperidone                                67   \n",
       "\n",
       "    DeepDDI output sentence for the corresponding DDI type  \\\n",
       "529  The serum concentration of Bepridil can be inc...       \n",
       "530  The metabolism of Oxycodone can be decreased w...       \n",
       "531  The metabolism of Quinidine can be decreased w...       \n",
       "532  The serum concentration of Temsirolimus can be...       \n",
       "533  The metabolism of Toremifene can be decreased ...       \n",
       "534  The metabolism of Oxycodone can be decreased w...       \n",
       "535  The serum concentration of Temsirolimus can be...       \n",
       "536  The metabolism of Clozapine can be decreased w...       \n",
       "537  The metabolism of Etodolac can be decreased wh...       \n",
       "538  Terbutaline may increase the atrioventricular ...       \n",
       "539  The metabolism of Clozapine can be decreased w...       \n",
       "540  The metabolism of Leflunomide can be decreased...       \n",
       "541  Ticagrelor may increase the anticoagulant acti...       \n",
       "542  The serum concentration of Ibrutinib can be in...       \n",
       "543  The metabolism of Apixaban can be decreased wh...       \n",
       "544  Tizanidine may decrease the antihypertensive a...       \n",
       "545  Tizanidine may increase the hypotensive activi...       \n",
       "546  Tizanidine may increase the hypotensive activi...       \n",
       "547  Tizanidine may increase the antihypertensive a...       \n",
       "548  Tizanidine may increase the hypotensive activi...       \n",
       "549  Tizanidine may increase the hypotensive activi...       \n",
       "550  Tizanidine may increase the bradycardic activi...       \n",
       "551  Tizanidine may increase the hypotensive activi...       \n",
       "552  The metabolism of Cyclobenzaprine can be decre...       \n",
       "553  The serum concentration of Dicyclomine can be ...       \n",
       "554  Topiramate may increase the central nervous sy...       \n",
       "555  The metabolism of Iloperidone can be decreased...       \n",
       "556  Topiramate may increase the central nervous sy...       \n",
       "557  Topiramate may increase the central nervous sy...       \n",
       "558  Topiramate may increase the hypotensive activi...       \n",
       "..                                                 ...       \n",
       "609  The metabolism of Lorcaserin can be decreased ...       \n",
       "610  The metabolism of Maprotiline can be decreased...       \n",
       "611  The serum concentration of Milnacipran can be ...       \n",
       "612  The metabolism of Selegiline can be decreased ...       \n",
       "613  The metabolism of Sertraline can be decreased ...       \n",
       "614  The metabolism of Tapentadol can be decreased ...       \n",
       "615  The metabolism of Tranylcypromine can be decre...       \n",
       "616  The metabolism of Trimipramine can be decrease...       \n",
       "617  Verapamil may increase the bradycardic activit...       \n",
       "618  The serum concentration of Carvedilol can be i...       \n",
       "619  The metabolism of Flecainide can be decreased ...       \n",
       "620  The serum concentration of Flibanserin can be ...       \n",
       "621  The metabolism of Guanfacine can be decreased ...       \n",
       "622  The metabolism of Oxycodone can be decreased w...       \n",
       "623  The metabolism of Nortriptyline can be decreas...       \n",
       "624  Vorapaxar may increase the anticoagulant activ...       \n",
       "625  Vorapaxar may increase the anticoagulant activ...       \n",
       "626  Vorapaxar may increase the anticoagulant activ...       \n",
       "627  Vorapaxar may increase the anticoagulant activ...       \n",
       "628  The serum concentration of Warfarin can be inc...       \n",
       "629  The metabolism of Bepridil can be decreased wh...       \n",
       "630  The metabolism of Oxycodone can be decreased w...       \n",
       "631  The metabolism of Toremifene can be decreased ...       \n",
       "632  The metabolism of Vinblastine can be decreased...       \n",
       "633  The metabolism of Vinorelbine can be decreased...       \n",
       "634  Vortioxetine may increase the neuroexcitatory ...       \n",
       "635  The metabolism of Topiramate can be decreased ...       \n",
       "636  The metabolism of Trifluoperazine can be decre...       \n",
       "637  The serum concentration of Aripiprazole can be...       \n",
       "638  Zonisamide may increase the hypotensive activi...       \n",
       "\n",
       "    Consistent with information on the corresponding DDI in Drugs.com?  \n",
       "529                                                Yes                  \n",
       "530                                                Yes                  \n",
       "531                                                Yes                  \n",
       "532                                                Yes                  \n",
       "533                                                Yes                  \n",
       "534                                                Yes                  \n",
       "535                                                Yes                  \n",
       "536                                                 No                  \n",
       "537                                                 No                  \n",
       "538                                                 No                  \n",
       "539                                                 No                  \n",
       "540                                                 No                  \n",
       "541                                                Yes                  \n",
       "542                                                 No                  \n",
       "543                                                 No                  \n",
       "544                                                 No                  \n",
       "545                                                Yes                  \n",
       "546                                                Yes                  \n",
       "547                                                 No                  \n",
       "548                                                Yes                  \n",
       "549                                                Yes                  \n",
       "550                                                 No                  \n",
       "551                                                Yes                  \n",
       "552                                                 No                  \n",
       "553                                                 No                  \n",
       "554                                                 No                  \n",
       "555                                                 No                  \n",
       "556                                                 No                  \n",
       "557                                                 No                  \n",
       "558                                                 No                  \n",
       "..                                                 ...                  \n",
       "609                                                 No                  \n",
       "610                                                 No                  \n",
       "611                                                 No                  \n",
       "612                                                 No                  \n",
       "613                                                 No                  \n",
       "614                                                 No                  \n",
       "615                                                 No                  \n",
       "616                                                 No                  \n",
       "617                                                Yes                  \n",
       "618                                                 No                  \n",
       "619                                                 No                  \n",
       "620                                                Yes                  \n",
       "621                                                Yes                  \n",
       "622                                                Yes                  \n",
       "623                                                 No                  \n",
       "624                                                Yes                  \n",
       "625                                                Yes                  \n",
       "626                                                Yes                  \n",
       "627                                                Yes                  \n",
       "628                                                 No                  \n",
       "629                                                 No                  \n",
       "630                                                Yes                  \n",
       "631                                                Yes                  \n",
       "632                                                Yes                  \n",
       "633                                                 No                  \n",
       "634                                                 No                  \n",
       "635                                                 No                  \n",
       "636                                                 No                  \n",
       "637                                                 No                  \n",
       "638                                                 No                  \n",
       "\n",
       "[110 rows x 4 columns]"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "val_data.tail(110)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T00:31:56.630395Z",
     "start_time": "2019-07-08T00:31:56.623559Z"
    }
   },
   "outputs": [],
   "source": [
    "df = val_data.loc[val_data['Consistent with information on the corresponding DDI in Drugs.com?'] == 'Yes']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T00:31:57.169707Z",
     "start_time": "2019-07-08T00:31:57.165155Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Names of drugs in pair', 'DDI type predicted using DeepDDI',\n",
       "       'DeepDDI output sentence for the corresponding DDI type',\n",
       "       'Consistent with information on the corresponding DDI in Drugs.com?'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T00:31:57.671436Z",
     "start_time": "2019-07-08T00:31:57.666666Z"
    }
   },
   "outputs": [],
   "source": [
    "df = df.rename(columns={\"DeepDDI output sentence for the corresponding DDI type\":\"Relation\", \n",
    "                        \"Names of drugs in pair\": \"Drug_Pair\"})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T00:31:58.128474Z",
     "start_time": "2019-07-08T00:31:58.122358Z"
    }
   },
   "outputs": [],
   "source": [
    "val_set = df[['Drug_Pair', 'Relation']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:01:10.048028Z",
     "start_time": "2019-07-08T01:01:10.036291Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Relation</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Drug_Pair</th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Amiloride;Enalapril</th>\n",
       "      <td>Amiloride may increase the hyperkalemic activi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Amiloride;Lisinopril</th>\n",
       "      <td>Amiloride may increase the hyperkalemic activi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Amiloride;Ramipril</th>\n",
       "      <td>Amiloride may increase the hyperkalemic activi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Amiloride;Trandolapril</th>\n",
       "      <td>Amiloride may increase the hyperkalemic activi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Amiodarone;Oxycodone</th>\n",
       "      <td>The metabolism of Oxycodone can be decreased w...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                 Relation\n",
       "Drug_Pair                                                                \n",
       "Amiloride;Enalapril     Amiloride may increase the hyperkalemic activi...\n",
       "Amiloride;Lisinopril    Amiloride may increase the hyperkalemic activi...\n",
       "Amiloride;Ramipril      Amiloride may increase the hyperkalemic activi...\n",
       "Amiloride;Trandolapril  Amiloride may increase the hyperkalemic activi...\n",
       "Amiodarone;Oxycodone    The metabolism of Oxycodone can be decreased w..."
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "val_set.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:01:15.056173Z",
     "start_time": "2019-07-08T01:01:15.050644Z"
    }
   },
   "outputs": [],
   "source": [
    "import importlib\n",
    "import os \n",
    "os.chdir('/Users/shristi/Documents/InsightDataProject/PythonScripts/')\n",
    "import relation\n",
    "importlib.reload(relation)\n",
    "from relation import normalizeRelation, filter_unknown_relations, get_relation_class"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:01:34.200895Z",
     "start_time": "2019-07-08T01:01:34.182371Z"
    }
   },
   "outputs": [],
   "source": [
    "val_relations = []\n",
    "val_set_dict = val_set.to_dict()['Relation']\n",
    "for k,v in val_set_dict.items():\n",
    "    #print(k)\n",
    "    #print(v)\n",
    "    d1, d2 = k.split(';')\n",
    "    #print((d1,d2))\n",
    "    val_relations.append(get_relation_class((d1, d2), v))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:01:35.981781Z",
     "start_time": "2019-07-08T01:01:34.714912Z"
    }
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import sklearn\n",
    "import joblib\n",
    "import pickle\n",
    "import modeling\n",
    "importlib.reload(modeling)\n",
    "from modeling import predict_val_set"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:01:44.026317Z",
     "start_time": "2019-07-08T01:01:35.983915Z"
    }
   },
   "outputs": [],
   "source": [
    "rf = joblib.load('/Users/shristi/Documents/InsightDataProject/Models/RFmodel01.joblib')\n",
    "\n",
    "infile = open('/Users/shristi/Documents/InsightDataProject/Data/ProcessedData/fingerprints.pkl','rb')\n",
    "fingerprints = pickle.load(infile)\n",
    "fingerprints.index = fingerprints.index.str.lower()\n",
    "name_to_fingerprints = fingerprints[['Molecular_Fingerprint']]\n",
    "name_to_fingerprints_dict = name_to_fingerprints.to_dict()['Molecular_Fingerprint']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:01:44.035936Z",
     "start_time": "2019-07-08T01:01:44.028931Z"
    }
   },
   "outputs": [],
   "source": [
    "label_map = {'adverse effects increased': 0, 'bioavailability decreased': 1, 'decrease absorption': 2, 'decrease anticoagulant activities': 3, 'decrease antihypertensive activities': 4, 'decrease bronchodilatory activities': 5, 'decrease cardiotoxic activities': 6, 'decrease diuretic activities': 7, 'decrease excretion rate': 8, 'decrease sedative activities': 9, 'decrease the stimulatory activities': 10, 'increase analgesic activities': 11, 'increase anticholinergic activities': 12, 'increase anticoagulant activities': 13, 'increase antihypertensive activities': 14, 'increase antiplatelet activities': 15, 'increase arrhythmogenic activities': 16, 'increase atrioventricular blocking activities': 17, 'increase bradycardic activities': 18, 'increase cardiotoxic activities': 19, 'increase central nervous system depressant activities': 20, 'increase fluid retaining activities': 21, 'increase hyperkalemic activities': 22, 'increase hypertensive activities': 23, 'increase hypoglycemic activities': 24, 'increase hypokalemic activities': 25, 'increase hypotensive activities': 26, 'increase immunosuppressive activities': 27, 'increase nephrotoxic activities': 28, 'increase neuroexcitatory activities': 29, 'increase neuromuscular blocking activities': 30, 'increase respiratory depressant': 31, 'increase sedative activities': 32, 'increase serotonergic activities': 33, 'metabolism decreased': 34, 'metabolism increased': 35, 'serum concentration decreased': 36, 'serum concentration increased': 37, 'serum concentration metabolites reduced': 38, 'therapeutic efficacy decreased': 39}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:01:44.042024Z",
     "start_time": "2019-07-08T01:01:44.038454Z"
    }
   },
   "outputs": [],
   "source": [
    "reverse_label_map = {v:k for k, v in label_map.items()}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:01:46.017297Z",
     "start_time": "2019-07-08T01:01:44.043940Z"
    }
   },
   "outputs": [],
   "source": [
    "predictions = {}\n",
    "for val_relation in val_relations: \n",
    "    #print(val_relation)\n",
    "    drug_pair = (val_relation.subject, val_relation.object)\n",
    "    res = predict_val_set(rf, drug_pair, name_to_fingerprints_dict)\n",
    "    interaction = reverse_label_map[res[0]]\n",
    "    predictions[drug_pair] = interaction"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:01:46.024647Z",
     "start_time": "2019-07-08T01:01:46.018976Z"
    }
   },
   "outputs": [],
   "source": [
    "predictions_df = pd.DataFrame.from_dict(predictions, orient= 'index', columns = ['Predicted_interactions'])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:01:51.436032Z",
     "start_time": "2019-07-08T01:01:51.422593Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Predicted_interactions</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>(amiloride, enalapril)</th>\n",
       "      <td>adverse effects increased</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(amiloride, lisinopril)</th>\n",
       "      <td>adverse effects increased</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(amiloride, ramipril)</th>\n",
       "      <td>adverse effects increased</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(amiloride, trandolapril)</th>\n",
       "      <td>adverse effects increased</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>(amiodarone, oxycodone)</th>\n",
       "      <td>metabolism decreased</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                              Predicted_interactions\n",
       "(amiloride, enalapril)     adverse effects increased\n",
       "(amiloride, lisinopril)    adverse effects increased\n",
       "(amiloride, ramipril)      adverse effects increased\n",
       "(amiloride, trandolapril)  adverse effects increased\n",
       "(amiodarone, oxycodone)         metabolism decreased"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "predictions_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:01:55.521020Z",
     "start_time": "2019-07-08T01:01:55.516455Z"
    }
   },
   "outputs": [],
   "source": [
    "real_interactions = {}\n",
    "for elem in val_relations: \n",
    "    drug_pair = (elem.subject,elem.object)\n",
    "    real_interactions[drug_pair] = elem.normalizedRelation\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:03:14.967272Z",
     "start_time": "2019-07-08T01:03:14.960872Z"
    }
   },
   "outputs": [],
   "source": [
    "real_interactions_df = pd.DataFrame.from_dict(real_interactions, orient= 'index', columns = ['Real_interactions'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:03:15.864540Z",
     "start_time": "2019-07-08T01:03:15.856664Z"
    }
   },
   "outputs": [],
   "source": [
    "final_df = pd.concat([real_interactions_df, predictions_df], axis=1, join_axes=[real_interactions_df.index])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:03:16.628250Z",
     "start_time": "2019-07-08T01:03:16.618401Z"
    }
   },
   "outputs": [],
   "source": [
    "final_df['index1'] = final_df.index\n",
    "final_df.index = list(range(final_df.shape[0]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:03:17.554103Z",
     "start_time": "2019-07-08T01:03:17.512335Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Real_interactions</th>\n",
       "      <th>Predicted_interactions</th>\n",
       "      <th>index1</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>increase hyperkalemic activities</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(amiloride, enalapril)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>increase hyperkalemic activities</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(amiloride, lisinopril)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>increase hyperkalemic activities</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(amiloride, ramipril)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>increase hyperkalemic activities</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(amiloride, trandolapril)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(amiodarone, oxycodone)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>None</td>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>(amitriptyline, citalopram)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>None</td>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>(amitriptyline, escitalopram)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>None</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(amoxapine, citalopram)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>None</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(amoxapine, escitalopram)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>serum concentration decreased</td>\n",
       "      <td>(amprenavir, temsirolimus)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>increase anticoagulant activities</td>\n",
       "      <td>increase anticoagulant activities</td>\n",
       "      <td>(anagrelide, apixaban)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>(aprepitant, oxycodone)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>None</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(aripiprazole, tetrabenazine)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(atazanavir, oxycodone)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>(atazanavir, temsirolimus)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(atazanavir, toremifene)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>increase hyperkalemic activities</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(azilsartan medoxomil, spironolactone)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>(bepridil, conivaptan)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(boceprevir, oxycodone)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>(boceprevir, temsirolimus)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(boceprevir, toremifene)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(bupropion, citalopram)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>(bupropion, fluoxetine)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(bupropion, fluvoxamine)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(bupropion, paroxetine)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>increase anticoagulant activities</td>\n",
       "      <td>increase anticoagulant activities</td>\n",
       "      <td>(cangrelor, apixaban)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>None</td>\n",
       "      <td>increase hypotensive activities</td>\n",
       "      <td>(chlorpromazine, sotalol)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(cimetidine, phenytoin)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(clarithromycin, oxycodone)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(clarithromycin, temsirolimus)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>152</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(telaprevir, oxycodone)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(telaprevir, quinidine)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>154</th>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>(telaprevir, temsirolimus)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(telaprevir, toremifene)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>156</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(telithromycin, oxycodone)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(telithromycin, temsirolimus)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>increase anticoagulant activities</td>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>(ticagrelor, apixaban)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>159</th>\n",
       "      <td>increase hypotensive activities</td>\n",
       "      <td>increase hypotensive activities</td>\n",
       "      <td>(tizanidine, fenoldopam)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160</th>\n",
       "      <td>increase hypotensive activities</td>\n",
       "      <td>increase hypotensive activities</td>\n",
       "      <td>(tizanidine, hydroflumethiazide)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161</th>\n",
       "      <td>increase hypotensive activities</td>\n",
       "      <td>increase hypotensive activities</td>\n",
       "      <td>(tizanidine, phenoxybenzamine)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>162</th>\n",
       "      <td>increase hypotensive activities</td>\n",
       "      <td>increase hypotensive activities</td>\n",
       "      <td>(tizanidine, phentolamine)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>163</th>\n",
       "      <td>increase hypotensive activities</td>\n",
       "      <td>increase hypotensive activities</td>\n",
       "      <td>(tizanidine, tolazoline)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>164</th>\n",
       "      <td>increase hypertensive activities</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(tranylcypromine, rasagiline)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>165</th>\n",
       "      <td>None</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(trazodone, methadone)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>166</th>\n",
       "      <td>increase hyperkalemic activities</td>\n",
       "      <td>increase hyperkalemic activities</td>\n",
       "      <td>(triamterene, enalapril)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>167</th>\n",
       "      <td>increase hyperkalemic activities</td>\n",
       "      <td>increase hyperkalemic activities</td>\n",
       "      <td>(triamterene, lisinopril)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>168</th>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(trifluoperazine, thioridazine)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>(triflupromazine, thioridazine)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>170</th>\n",
       "      <td>increase hyperkalemic activities</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(valsartan, amiloride)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>increase bradycardic activities</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(verapamil, bisoprolol)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>172</th>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>serum concentration increased</td>\n",
       "      <td>(verapamil, flibanserin)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>173</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(verapamil, guanfacine)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>174</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(verapamil, oxycodone)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>175</th>\n",
       "      <td>increase anticoagulant activities</td>\n",
       "      <td>increase anticoagulant activities</td>\n",
       "      <td>(vorapaxar, apixaban)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>176</th>\n",
       "      <td>increase anticoagulant activities</td>\n",
       "      <td>increase anticoagulant activities</td>\n",
       "      <td>(vorapaxar, argatroban)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>177</th>\n",
       "      <td>increase anticoagulant activities</td>\n",
       "      <td>increase anticoagulant activities</td>\n",
       "      <td>(vorapaxar, bivalirudin)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>178</th>\n",
       "      <td>increase anticoagulant activities</td>\n",
       "      <td>increase anticoagulant activities</td>\n",
       "      <td>(vorapaxar, edoxaban)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(voriconazole, oxycodone)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(voriconazole, toremifene)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>181</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(voriconazole, vinblastine)</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>182 rows Ã— 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                     Real_interactions             Predicted_interactions  \\\n",
       "0     increase hyperkalemic activities          adverse effects increased   \n",
       "1     increase hyperkalemic activities          adverse effects increased   \n",
       "2     increase hyperkalemic activities          adverse effects increased   \n",
       "3     increase hyperkalemic activities          adverse effects increased   \n",
       "4                 metabolism decreased               metabolism decreased   \n",
       "5                                 None      serum concentration increased   \n",
       "6                                 None      serum concentration increased   \n",
       "7                                 None          adverse effects increased   \n",
       "8                                 None          adverse effects increased   \n",
       "9        serum concentration increased      serum concentration decreased   \n",
       "10   increase anticoagulant activities  increase anticoagulant activities   \n",
       "11       serum concentration increased      serum concentration increased   \n",
       "12                                None          adverse effects increased   \n",
       "13                metabolism decreased               metabolism decreased   \n",
       "14       serum concentration increased      serum concentration increased   \n",
       "15                metabolism decreased               metabolism decreased   \n",
       "16    increase hyperkalemic activities          adverse effects increased   \n",
       "17       serum concentration increased      serum concentration increased   \n",
       "18                metabolism decreased               metabolism decreased   \n",
       "19       serum concentration increased      serum concentration increased   \n",
       "20                metabolism decreased               metabolism decreased   \n",
       "21                metabolism decreased               metabolism decreased   \n",
       "22                metabolism decreased      serum concentration increased   \n",
       "23                metabolism decreased               metabolism decreased   \n",
       "24                metabolism decreased               metabolism decreased   \n",
       "25   increase anticoagulant activities  increase anticoagulant activities   \n",
       "26                                None    increase hypotensive activities   \n",
       "27       serum concentration increased               metabolism decreased   \n",
       "28                metabolism decreased               metabolism decreased   \n",
       "29       serum concentration increased               metabolism decreased   \n",
       "..                                 ...                                ...   \n",
       "152               metabolism decreased               metabolism decreased   \n",
       "153               metabolism decreased               metabolism decreased   \n",
       "154      serum concentration increased      serum concentration increased   \n",
       "155               metabolism decreased               metabolism decreased   \n",
       "156               metabolism decreased               metabolism decreased   \n",
       "157      serum concentration increased               metabolism decreased   \n",
       "158  increase anticoagulant activities      serum concentration increased   \n",
       "159    increase hypotensive activities    increase hypotensive activities   \n",
       "160    increase hypotensive activities    increase hypotensive activities   \n",
       "161    increase hypotensive activities    increase hypotensive activities   \n",
       "162    increase hypotensive activities    increase hypotensive activities   \n",
       "163    increase hypotensive activities    increase hypotensive activities   \n",
       "164   increase hypertensive activities          adverse effects increased   \n",
       "165                               None          adverse effects increased   \n",
       "166   increase hyperkalemic activities   increase hyperkalemic activities   \n",
       "167   increase hyperkalemic activities   increase hyperkalemic activities   \n",
       "168      serum concentration increased          adverse effects increased   \n",
       "169      serum concentration increased      serum concentration increased   \n",
       "170   increase hyperkalemic activities               metabolism decreased   \n",
       "171    increase bradycardic activities          adverse effects increased   \n",
       "172      serum concentration increased      serum concentration increased   \n",
       "173               metabolism decreased               metabolism decreased   \n",
       "174               metabolism decreased               metabolism decreased   \n",
       "175  increase anticoagulant activities  increase anticoagulant activities   \n",
       "176  increase anticoagulant activities  increase anticoagulant activities   \n",
       "177  increase anticoagulant activities  increase anticoagulant activities   \n",
       "178  increase anticoagulant activities  increase anticoagulant activities   \n",
       "179               metabolism decreased               metabolism decreased   \n",
       "180               metabolism decreased               metabolism decreased   \n",
       "181               metabolism decreased               metabolism decreased   \n",
       "\n",
       "                                     index1  \n",
       "0                    (amiloride, enalapril)  \n",
       "1                   (amiloride, lisinopril)  \n",
       "2                     (amiloride, ramipril)  \n",
       "3                 (amiloride, trandolapril)  \n",
       "4                   (amiodarone, oxycodone)  \n",
       "5               (amitriptyline, citalopram)  \n",
       "6             (amitriptyline, escitalopram)  \n",
       "7                   (amoxapine, citalopram)  \n",
       "8                 (amoxapine, escitalopram)  \n",
       "9                (amprenavir, temsirolimus)  \n",
       "10                   (anagrelide, apixaban)  \n",
       "11                  (aprepitant, oxycodone)  \n",
       "12            (aripiprazole, tetrabenazine)  \n",
       "13                  (atazanavir, oxycodone)  \n",
       "14               (atazanavir, temsirolimus)  \n",
       "15                 (atazanavir, toremifene)  \n",
       "16   (azilsartan medoxomil, spironolactone)  \n",
       "17                   (bepridil, conivaptan)  \n",
       "18                  (boceprevir, oxycodone)  \n",
       "19               (boceprevir, temsirolimus)  \n",
       "20                 (boceprevir, toremifene)  \n",
       "21                  (bupropion, citalopram)  \n",
       "22                  (bupropion, fluoxetine)  \n",
       "23                 (bupropion, fluvoxamine)  \n",
       "24                  (bupropion, paroxetine)  \n",
       "25                    (cangrelor, apixaban)  \n",
       "26                (chlorpromazine, sotalol)  \n",
       "27                  (cimetidine, phenytoin)  \n",
       "28              (clarithromycin, oxycodone)  \n",
       "29           (clarithromycin, temsirolimus)  \n",
       "..                                      ...  \n",
       "152                 (telaprevir, oxycodone)  \n",
       "153                 (telaprevir, quinidine)  \n",
       "154              (telaprevir, temsirolimus)  \n",
       "155                (telaprevir, toremifene)  \n",
       "156              (telithromycin, oxycodone)  \n",
       "157           (telithromycin, temsirolimus)  \n",
       "158                  (ticagrelor, apixaban)  \n",
       "159                (tizanidine, fenoldopam)  \n",
       "160        (tizanidine, hydroflumethiazide)  \n",
       "161          (tizanidine, phenoxybenzamine)  \n",
       "162              (tizanidine, phentolamine)  \n",
       "163                (tizanidine, tolazoline)  \n",
       "164           (tranylcypromine, rasagiline)  \n",
       "165                  (trazodone, methadone)  \n",
       "166                (triamterene, enalapril)  \n",
       "167               (triamterene, lisinopril)  \n",
       "168         (trifluoperazine, thioridazine)  \n",
       "169         (triflupromazine, thioridazine)  \n",
       "170                  (valsartan, amiloride)  \n",
       "171                 (verapamil, bisoprolol)  \n",
       "172                (verapamil, flibanserin)  \n",
       "173                 (verapamil, guanfacine)  \n",
       "174                  (verapamil, oxycodone)  \n",
       "175                   (vorapaxar, apixaban)  \n",
       "176                 (vorapaxar, argatroban)  \n",
       "177                (vorapaxar, bivalirudin)  \n",
       "178                   (vorapaxar, edoxaban)  \n",
       "179               (voriconazole, oxycodone)  \n",
       "180              (voriconazole, toremifene)  \n",
       "181             (voriconazole, vinblastine)  \n",
       "\n",
       "[182 rows x 3 columns]"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "final_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:03:21.541412Z",
     "start_time": "2019-07-08T01:03:21.503481Z"
    }
   },
   "outputs": [],
   "source": [
    "status = []\n",
    "for index, row in final_df.iterrows():\n",
    "    if row['Real_interactions'] is None: \n",
    "        status.append('Fingerprints unavailable')\n",
    "    elif row['Real_interactions'] == row['Predicted_interactions']:\n",
    "        status.append('correct')\n",
    "    else: \n",
    "        status.append('incorrect')\n",
    "final_df['status'] = status"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:03:21.874695Z",
     "start_time": "2019-07-08T01:03:21.861061Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Real_interactions</th>\n",
       "      <th>Predicted_interactions</th>\n",
       "      <th>index1</th>\n",
       "      <th>status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>increase hyperkalemic activities</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(amiloride, enalapril)</td>\n",
       "      <td>incorrect</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>increase hyperkalemic activities</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(amiloride, lisinopril)</td>\n",
       "      <td>incorrect</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>increase hyperkalemic activities</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(amiloride, ramipril)</td>\n",
       "      <td>incorrect</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>increase hyperkalemic activities</td>\n",
       "      <td>adverse effects increased</td>\n",
       "      <td>(amiloride, trandolapril)</td>\n",
       "      <td>incorrect</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>metabolism decreased</td>\n",
       "      <td>(amiodarone, oxycodone)</td>\n",
       "      <td>correct</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                  Real_interactions     Predicted_interactions  \\\n",
       "0  increase hyperkalemic activities  adverse effects increased   \n",
       "1  increase hyperkalemic activities  adverse effects increased   \n",
       "2  increase hyperkalemic activities  adverse effects increased   \n",
       "3  increase hyperkalemic activities  adverse effects increased   \n",
       "4              metabolism decreased       metabolism decreased   \n",
       "\n",
       "                      index1     status  \n",
       "0     (amiloride, enalapril)  incorrect  \n",
       "1    (amiloride, lisinopril)  incorrect  \n",
       "2      (amiloride, ramipril)  incorrect  \n",
       "3  (amiloride, trandolapril)  incorrect  \n",
       "4    (amiodarone, oxycodone)    correct  "
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "final_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2019-07-08T01:04:01.212131Z",
     "start_time": "2019-07-08T01:04:01.055172Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "106 53\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<Figure size 432x288 with 0 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 792x576 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "plt.figure()\n",
    "sns.set(font_scale=2.5)\n",
    "import matplotlib.pyplot as plt\n",
    "labels = ['Correct Predictions', 'Incorrect Predictions']\n",
    "\n",
    "listofpredictions = list(final_df['status'])\n",
    "incorrect = 0\n",
    "correct = 0\n",
    "for i in range(len(listofpredictions)):\n",
    "    if listofpredictions[i] == 'incorrect': \n",
    "        incorrect = incorrect + 1\n",
    "    elif listofpredictions[i] == 'correct':\n",
    "        correct = correct + 1\n",
    "print(correct, incorrect)\n",
    "\n",
    "numbers = [106, 53]\n",
    "#sns.set(rc={'figure.figsize':(14.5,11.27)})\n",
    "#ax = sns.barplot(x=\"x\", y=\"x\",  estimator=lambda x: len(x) / len(df) * 100)\n",
    "plt.figure(figsize=(11,8))\n",
    "colors = ['lightskyblue', 'lightcoral']\n",
    "patches, texts = plt.pie(numbers, colors=colors, shadow=True, startangle=140)\n",
    "plt.legend(patches, labels, loc=\"best\")\n",
    "plt.axis('equal')\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "#ax = sns.barplot(x=\"status\", y=\"status\", data=df)\n",
    "#ax.set_title('Predictions on drug compounds from Drugs.com')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  },
  "toc": {
   "base_numbering": 1,
   "nav_menu": {},
   "number_sections": true,
   "sideBar": true,
   "skip_h1_title": false,
   "title_cell": "Table of Contents",
   "title_sidebar": "Contents",
   "toc_cell": false,
   "toc_position": {},
   "toc_section_display": true,
   "toc_window_display": true
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
